Skip to main content
Back
UNH logo

UnitedHealth Group Incorporated

Data quality: 100%
UNH
NYSE Healthcare Medical - Healthcare Plans
$272.28
▲ $2.74 (1.02%)
Mkt Cap: 247.14B
Day Range
$267.59 $273.38
52-Week Range
$234.60 $606.36
Volume
5,890,739
50D / 200D Avg
$298.51 / $314.23
Prev Close
$269.54

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 20.5 0.3
P/B 2.6 2.9
ROE % 12.9 3.7
Net Margin % 2.7 3.8
Rev Growth 5Y % 11.7 10.0
D/E 0.8 0.2

Analyst Price Target

Hold
$385.38 +41.5%
Low: $327.00 High: $444.00
Forward P/E
15.1
Forward EPS
$17.85
EPS Growth (est.)
+0.0%
Est. Revenue
440 B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $32.46
$31.77 – $34.06
 540 B 4
FY2029 $28.68
$28.07 – $30.10
 510 B 4
FY2028 $23.78
$22.33 – $26.27
 480 B 10

Insider Trading Activity

18 transactions
Date Insider Type Shares Price Value
Mar 17, 2026
Baker Charles D.
Director
 grant 14 — —
Feb 20, 2026
ROOS THOMAS E
Chief Accounting Officer
 other 326 $290.00 $94,540
Jan 2, 2026
Gottlieb Scott
Director
 grant 125 — —
Jan 2, 2026
Baker Charles D.
Director
 grant 279 — —
Dec 16, 2025
MCNABB FREDERICK WILLIAM III
Director
 grant 53 — —
Oct 1, 2025
FLYNN TIMOTHY PATRICK
Director
 grant 272 — —
Sep 23, 2025
FLYNN TIMOTHY PATRICK
Director
 grant 61 — —
Sep 23, 2025
MCNABB FREDERICK WILLIAM III
Director
 grant 49 — —
Sep 11, 2025
Baker Charles D.
Director
 sell 27 $356.05 $9,613
Jul 1, 2025
MONTGOMERY RICE VALERIE MD
Director
 grant 288 — —
Jul 1, 2025
Gil Kristen
Director
 grant 173 — —
Jun 24, 2025
Noseworthy John H
Director
 grant 42 — —
Jun 24, 2025
Noel Timothy John
Chief Executive Officer, UHC
 grant 48 — —
Jun 6, 2025
McSweeney Erin
EVP & Chief People Officer
 other 130 $303.22 $39,419
Jun 3, 2025
Zaetta Christopher R
EVP & Chief Legal Officer
 other 115 $301.22 $34,640
May 14, 2025
FLYNN TIMOTHY PATRICK
Director
 buy 1,533 $320.80 $491,786
Apr 1, 2025
Gil Kristen
Director
 grant 108 — —
Apr 1, 2025
HOOPER MICHELE J
Director
 grant 108 — —

Key Takeaways

Revenue grew 11.69% annually over 5 years — strong growth
Earnings declined -16.31% over the past year
ROE of 12.91% — decent returns on equity
Generating 16.08B in free cash flow
Cash machine — converts 133.34% of earnings into free cash flow
Capital efficient — spends only 0.81% of revenue on capex

Growth

Revenue Growth (5Y)
11.69%
Revenue (1Y)11.81%
Earnings (1Y)-16.31%
FCF Growth (3Y)-20.88%

Quality

Return on Equity
12.91%
ROIC8.25%
Net Margin2.69%
Op. Margin4.24%

Safety

Debt / Equity
0.83
Current Ratio0.79
Interest Coverage4.74

Valuation

P/E Ratio
20.50
P/B Ratio2.63
EV/EBITDA15.88
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.81% Revenue Growth (3Y) 9.74%
Earnings Growth (1Y) -16.31% Earnings Growth (3Y) -26.61%
Revenue Growth (5Y) 11.69% Earnings Growth (5Y) -8.61%
Profitability
Revenue (TTM) 447.57B Net Income (TTM) 12.06B
ROE 12.91% ROA 3.89%
Gross Margin 18.53% Operating Margin 4.24%
Net Margin 2.69% Free Cash Flow (TTM) 16.08B
ROIC 8.25% FCF Growth (3Y) -20.88%
Safety
Debt / Equity 0.83 Current Ratio 0.79
Interest Coverage 4.74 Dividend Yield 0.03%
Valuation
P/E Ratio 20.50 P/B Ratio 2.63
P/S Ratio 0.55 PEG Ratio -1.62
EV/EBITDA 15.88 Dividend Yield 0.03%
Market Cap 247.14B Enterprise Value 301.17B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 447.57B 400.28B 371.62B 324.16B 287.60B
Net Income 12.06B 14.41B 22.38B 20.12B 17.29B
EPS (Diluted) 13.23 15.51 23.86 21.18 18.08
Gross Profit 82.92B 89.40B 90.96B 79.62B 69.65B
Operating Income 18.96B 32.29B 32.36B 28.44B 23.97B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 309.58B 298.28B 273.72B 245.71B 212.21B
Total Liabilities 207.88B 195.69B 174.80B 159.36B 135.73B
Shareholders' Equity 94.11B 92.66B 88.76B 77.77B 71.76B
Total Debt 78.39B 76.90B 67.44B 57.62B 46.00B
Cash & Equivalents 24.37B 25.31B 25.43B 23.37B 21.38B
Current Assets 90.58B 85.78B 78.44B 69.07B 61.76B
Current Liabilities 114.90B 103.77B 99.05B 89.24B 78.29B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#250 of 1052
58
Growth Price/Sales Ratio Focus (Ken Fisher)
#284 of 618
37

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026